The present invention relates to solid pharmaceutical dosage forms suitable for use as drinking water medication. More in particular, the present invention provides solid pharmaceutical dosage forms comprising a pharmaceutically active agent, a non-ionic surfactant having an Hydrophilic Lipophilic Balance (HLB) of at least 8, and a maltodextrin. The present invention also provides the use of such pharmaceutical dosage forms in veterinary medicine, more in particular as drinking water medication; as well as methods for preparing such pharmaceutical dosage forms.

A flexible and collapsible liquid storage bag comprising front and back walls formed from a sheet material is described wherein a front wall and a back wall are joined along a perimeter of the bag and are also joined at a joined center portion proximate the centers of the respective front and back sheets. The bags are typically used in the storage, heat-treatment and dispensing of bovine colostrum.

The present application provides methods to promote growth and improve feed conversion in animals by administering to the animal an effective amount of a composition comprising PGN, MDP or an MDP analog, or a combination thereof.

The present invention provides a system for providing a health benefit to a companion animal comprising: a maintenance pet food comprising fat, protein, and carbohydrates, where the maintenance pet food can be complete and balanced and has a density ranging from 400 g/l to 600 g/l; and a reduced caloric pet food comprising fat, protein, and carbohydrates, where the reduced caloric pet food can be complete and balanced and has a density ranging from 300 g/l to 450 g/l. Generally, the reduced caloric pet food can have a caloric content of 50% to 90% of the maintenance pet food in about the same volume and the reduced caloric pet food can have a density of 70% to 85% of the maintenance pet food.

The present invention provides a system for providing a health benefit to a companion animal comprising: a maintenance pet food comprising fat, protein, and carbohydrates, where the maintenance pet food can be complete and balanced and has a density ranging from 400 g/l to 600 g/l; and a reduced caloric pet food comprising fat, protein, and carbohydrates, where the reduced caloric pet food can be complete and balanced and has a density ranging from 300 g/l to 450 g/l. Generally, the reduced caloric pet food can have a caloric content of 50% to 90% of the maintenance pet food in about the same volume and the reduced caloric pet food can have a density of 70% to 85% of the maintenance pet food.

Peptide-based neurokinin antagonists of fish reproduction are disclosed. Compositions comprising antagonists of fish neurokinin and methods of inhibiting or delaying puberty, fish maturation or reproduction processes using these compounds are also provided.

The present invention discloses a multiplier and modulator additive of the ruminal microbiota created from exogenous multienzyme compounds, integrating processes and devices for cultivating and harvesting biomass of selected fungal species, assembling active components of fungal origin and by mixing supplies according to specifications, forming thus a multiplier and modulator additive of the ruminal microbiota suitable for its application (as part of food or via distribution devices as a nutritional supplement) in the ruminant animal feed industry.

The present invention relates to a Myoviridae bacteriophage Esc-CHP-2 that is isolated from the nature and can kill specifically enteropathogenic E. coli strains, which has a genome represented by the nucleotide sequence of SEQ. ID. NO: 1 (Accession NO: KCTC 12661BP), and a method for preventing and treating the infections of enteropathogenic E. coli using the composition comprising said bacteriophage as an active ingredient.

The present invention relates to a Myoviridae bacteriophage Esc-CHP-2 that is isolated from the nature and can kill specifically enteropathogenic E. coli strains, which has a genome represented by the nucleotide sequence of SEQ. ID. NO: 1 (Accession NO: KCTC 12661BP), and a method for preventing and treating the infections of enteropathogenic E. coli using the composition comprising said bacteriophage as an active ingredient.

Palatable food products are provided with low bulk density of about 4-12 lb/ft.sup.3 and comprise an expanded matrix of intercommunicated pores defined by a skeletal structure of gelatinized starch. The products produce an audible crunch sound when crushed by applied force and include low calorie, energy-dense characteristics of about 2-6 Kcal/g. The total weight of the product comprises about 20-60% starch, about 30% or less flowable fat, about 2-12% water, and a coating of flavorants and/or aromants. The product can optionally comprise health promoting ingredients. The products are manufactured by extruding batched ingredients including starch and water under processing conditions to promote starch gelatinization to form a substantially homogenous dough that, after extrusion, expands into a porous matrix. The porous matrix can undergo vacuum infusion to fill the matrix with flowable fat, dry palatant, and wet palatant. After infusion, the porous matrix can be dust coated with dry palatant.